Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Absci Corporation (ABSI)
USD10.24
+0.03 (+0.29%)
US NASDAQ Healthcare Biotechnology
Address
18105 SE Mill Plain Boulevard 98683
Vancouver, WA, US
Vancouver, WA, US
CEO
Sean McClain
Website
absci.com
IPO
2021-07-22
CIK 1672688 ISIN US00091E1091
Description
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD10.24
+0.03 (+0.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
2.33
Float Shares
134.37M
Free Float %
86.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.03% | -0.52% | +93.96% | +138.84% | +70.00% | +65.62% | +97.27% | +362.40% | -73.23% | -73.23% | -73.23% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
10.24
Low
4.32
-57.8%
Consensus
6.16
-39.8%
Median
6.16
-39.8%
High
8.00
-21.9%
DCF (Unlevered)
0.04
-99.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
6.16
-39.8%
|
| All Time | 3 |
6.11
-40.3%
|
Quality scores
Altman Z-Score
16.76
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-38.2% Q1'26: -81.8% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+10.6% Q1'26: +9.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-4,069.2% Q1'26: -12,249.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-4,454.2% Q1'26: -14,347.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-247.2% Q1'26: -243.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+24.1% Q1'26: +22.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.05× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.78M
est: 5.05M (-5.4%)
|
5.75M
est: 9.31M (-38.3%)
|
5.72M
est: 3.25M (+75.9%)
|
4.53M
est: 6.05M (-25.1%)
|
2.80M
est: 3.70M (-24.3%)
|
7.92M
2.23M – 24.14M
+114.1% YoY
|
22.22M
2.09M – 75.80M
+180.5% YoY
|
66.29M
62.69M – 69.89M
+198.4% YoY
|
92.57M
12.91M – 269.96M
+39.6% YoY
|
129.69M
18.09M – 378.23M
+40.1% YoY
|
| EBITDA |
-67.68M
est: -5.05M (-1,239.2%)
|
-93.71M
est: -9.31M (-906.9%)
|
-79.68M
est: -3.25M (-2,351.7%)
|
-94.10M
est: -6.05M (-1,454.3%)
|
-112.98M
est: -3.70M (-2,953.4%)
|
-7.92M
-24.14M – -2.23M
-114.1% YoY
|
-22.22M
-75.80M – -2.09M
-180.5% YoY
|
-66.29M
-69.89M – -62.69M
-198.4% YoY
|
-92.57M
-269.96M – -12.91M
-39.6% YoY
|
-129.69M
-378.23M – -18.09M
-40.1% YoY
|
| EBIT |
-74.34M
est: -5.05M (-1,370.8%)
|
-106.75M
est: -9.31M (-1,047.0%)
|
-93.68M
est: -3.25M (-2,782.5%)
|
-107.49M
est: -6.05M (-1,675.4%)
|
-124.72M
est: -3.70M (-3,270.8%)
|
-7.92M
-24.14M – -2.23M
-114.1% YoY
|
-22.22M
-75.80M – -2.09M
-180.5% YoY
|
-66.29M
-69.89M – -62.69M
-198.4% YoY
|
-92.57M
-269.96M – -12.91M
-39.6% YoY
|
-129.69M
-378.23M – -18.09M
-40.1% YoY
|
| Net Income |
-100.96M
est: -209.49M (+51.8%)
|
-104.90M
est: -111.76M (+6.1%)
|
-110.57M
est: -92.26M (-19.8%)
|
-103.11M
est: -113.30M (+9.0%)
|
-115.18M
est: -115.18M (+0.0%)
|
-102.32M
-120.75M – -83.89M
+11.2% YoY
|
-114.94M
-143.71M – -49.62M
-12.3% YoY
|
-79.33M
-117.33M – 14.85M
+31.0% YoY
|
-46.50M
-162.36M – 5.52M
+41.4% YoY
|
9.57M
-1.14M – 33.43M
+120.6% YoY
|
| SGA |
—
est: 1.16M (-100.0%)
|
—
est: 2.14M (-100.0%)
|
—
est: 8.14M (-100.0%)
|
—
est: 15.16M (-100.0%)
|
35.06M
est: 9.27M (+278.4%)
|
19.83M
5.60M – 60.44M
+114.1% YoY
|
55.64M
5.23M – 189.80M
+180.5% YoY
|
166.01M
157.00M – 175.02M
+198.4% YoY
|
231.80M
32.32M – 676.02M
+39.6% YoY
|
324.77M
45.29M – 947.15M
+40.1% YoY
|
| EPS |
-1.11
est: -1.90 (+41.6%)
|
-1.15
est: -1.17 (+1.4%)
|
-1.20
est: -0.93 (-29.1%)
|
-0.94
est: -0.86 (-8.8%)
|
-0.84
est: -0.83 (-1.7%)
|
-0.77
-0.88 – -0.61
+6.6% YoY
|
-0.74
-1.05 – -0.36
+4.3% YoY
|
-0.45
-0.86 – 0.11
+38.6% YoY
|
-0.34
-1.19 – 0.04
+25.0% YoY
|
0.07
-0.01 – 0.24
+120.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-123.48M
OE per share TTM
-0.85
Owner's Yield
-14.04%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
782.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
35
Total invested
8.01M
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Phoenix General Partner II LLC | 14.49M | 15.70% | 14.49M | — | 14.49M | — | OO | Delaware | 2022-02-14 | ↗ |
| 2 | Phoenix Venture Partners II, LP | 14.49M | 15.70% | 14.49M | — | 14.49M | — | PN | Delaware | 2022-02-14 | ↗ |
| 3 | Abigail P. Johnson | 12.73M | 11.21% | — | — | 12.73M | — | IN | Delaware | 2024-11-12 | ↗ |
| 4 | FMR LLC | 12.73M | 11.21% | 12.73M | — | 12.73M | — | HC | Delaware | 2024-11-12 | ↗ |
| 5 | Sean McClain | 9.37M | 10.00% | — | — | — | — | IN | Citizenship or Place of Organization: | 2024-02-13 | ↗ |
| 6 | 9.5%(3) | 8.79M | 9.50% | 8.79M | — | 6.51M | — | IN | — | 2022-02-11 | ↗ |
| 7 | Jeremy C. Green | 8.03M | 8.70% | — | 8.03M | — | 8.03M | HC, IN | — | 2021-08-02 | ↗ |
| 8 | Redmile Group, LLC | 8.03M | 8.70% | — | 8.03M | — | 8.03M | IA, OO | — | 2021-08-02 | ↗ |
| 9 | 2. | 7.57M | 12.00% | 7.57M | — | 7.57M | — | HC | New York | 2024-11-14 | ↗ |
| 10 | Redmile Biopharma Investments II, L.P. | 6.16M | 6.70% | — | 6.16M | — | 6.16M | PN | — | 2021-08-02 | ↗ |
| 11 | (1) BlackRock, Inc. | 5.78M | 5.10% | 5.72M | — | 5.78M | — | HC | Delaware | 2024-11-08 | ↗ |
| 12 | 10. | 5.54M | 6.00% | 5.54M | — | 5.54M | — | IN | — | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
35
-113 vs prev Q
New positions
9
Closed positions
116
Increased
18
Reduced
6
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADVANCED MICRO DEVICES INC | 5.71M +5.7M (+100.0%) | 19.94B +19.9B (+100.0%) | 3.97% +3.975 pp | 10.35% +10.350 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 2 | — | 37.7K +37.7K (+100.0%) | 131.40M +131.4M (+100.0%) | 0.03% +0.026 pp | 0.11% +0.107 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 3 | FMR LLC | 22.38M +298.5K (+1.4%) | 78.11M +11.0M (+16.4%) | 15.57% -1.740 pp | 0.00% +0.001 pp | USD6.97 -49.9% | 18 qtrs — |
| 4 | ARK INVESTMENT MANAGEMENT LLC | 12.55M +388.0K (+3.2%) | 43.80M +6.8M (+18.5%) | 8.73% -0.803 pp | 0.29% +0.071 pp | USD3.55 -1.7% | 8 qtrs — |
| 5 | BLACKROCK, INC. | 11.33M +750.5K (+7.1%) | 39.55M +7.4M (+22.9%) | 7.88% -0.411 pp | 0.00% +0.000 pp | USD3.36 +3.9% | 6 qtrs — |
| 6 | REDMILE GROUP, LLC | 8.25M +— (+0.0%) | 28.80M +3.7M (+14.8%) | 5.74% -0.728 pp | 2.12% -0.320 pp | USD11.47 -69.6% | 18 qtrs — |
| 7 | VANGUARD GROUP INC | 7.91M +628.3K (+8.6%) | 27.61M +5.5M (+24.7%) | 5.50% -0.205 pp | 0.00% +0.000 pp | USD4.86 -28.2% | 18 qtrs — |
| 8 | STATE STREET CORP | 5.99M +3.9M (+190.1%) | 20.91M +14.6M (+233.1%) | 4.17% +2.549 pp | 0.00% +0.001 pp | USD3.43 +1.7% | 18 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 3.24M +186.7K (+6.1%) | 11.31M +2.0M (+21.8%) | 2.25% -0.139 pp | 0.00% +0.000 pp | USD3.59 -2.8% | 18 qtrs — |
| 10 | AMERIPRISE FINANCIAL INC | 3.20M +5.6K (+0.2%) | 11.16M +1.5M (+15.0%) | 2.22% -0.278 pp | 0.00% +0.000 pp | USD3.68 -5.2% | 9 qtrs — |
| 11 | UBS GROUP AG | 2.70M +706.4K (+35.4%) | 9.42M +3.4M (+55.5%) | 1.88% +0.316 pp | 0.00% +0.001 pp | USD2.85 +22.5% | 18 qtrs — |
| 12 | SCHONFELD STRATEGIC ADVISORS LLC | 2.35M +2.3M (+100.0%) | 8.20M +8.2M (+100.0%) | 1.63% +1.634 pp | 0.04% +0.036 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 13 | WOODLINE PARTNERS LP | 2.28M +510.7K (+28.9%) | 7.96M +2.6M (+47.9%) | 1.59% +0.199 pp | 0.03% +0.006 pp | USD3.46 +0.9% | 8 qtrs — |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.16M +2.1M (+2,955.4%) | 7.53M +7.3M (+3,400.5%) | 1.50% +1.444 pp | 0.00% +0.001 pp | USD3.48 +0.3% | 6 qtrs — |
| 15 | BAKER BROS. ADVISORS LP | 2.13M +2.1M (+100.0%) | 7.45M +7.5M (+100.0%) | 1.48% +1.485 pp | 0.04% +0.044 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 16 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.72M -488.5K (-22.1%) | 6.00M -711.1K (-10.6%) | 1.20% -0.535 pp | 0.00% 0.000 pp | USD2.51 +39.0% | 4 qtrs — |
| 17 | MORGAN STANLEY | 1.48M +509.0K (+52.5%) | 5.16M +2.2M (+75.0%) | 1.03% +0.269 pp | 0.00% +0.000 pp | USD3.19 +9.4% | 18 qtrs — |
| 18 | PARKMAN HEALTHCARE PARTNERS LLC | 1.46M +1.5M (+100.0%) | 5.09M +5.1M (+100.0%) | 1.01% +1.015 pp | 0.48% +0.485 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 19 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.42M -69.3K (-4.6%) | 4.97M +430.6K (+9.5%) | 0.99% -0.180 pp | 0.00% +0.000 pp | USD3.63 -3.9% | 8 qtrs — |
| 20 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.42M -69.3K (-4.6%) | 4.96M +416.3K (+9.2%) | 0.99% -0.180 pp | 0.06% +0.013 pp | USD3.63 -3.9% | 8 qtrs — |
| 21 | TWO SIGMA INVESTMENTS, LP | 1.42M +1.3M (+1,015.5%) | 4.95M +4.6M (+1,180.6%) | 0.99% +0.887 pp | 0.01% +0.006 pp | USD3.45 +1.2% | 14 qtrs — |
| 22 | FRED ALGER MANAGEMENT, LLC | 1.21M -26.1K (-2.1%) | 4.21M +463.6K (+12.4%) | 0.84% -0.127 pp | 0.02% +0.002 pp | USD5.54 -37.0% | 8 qtrs — |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.12M +20.6K (+1.9%) | 3.89M +564.6K (+17.0%) | 0.78% -0.082 pp | 0.00% +0.000 pp | USD2.71 +28.8% | 17 qtrs — |
| 24 | HEIGHTS CAPITAL MANAGEMENT, INC | 1.07M -934.8K (-46.7%) | 3.72M -2.4M (-38.8%) | 0.74% -0.827 pp | 1.33% -0.334 pp | USD3.04 +14.8% | 2 qtrs — |
| 25 | GOLDMAN SACHS GROUP INC | 1.02M +737.5K (+257.6%) | 3.57M +2.7M (+310.5%) | 0.71% +0.488 pp | 0.00% +0.000 pp | USD3.58 -2.5% | 17 qtrs — |
| 26 | NORTHERN TRUST CORP | 988.8K -44.9K (-4.3%) | 3.45M +308.4K (+9.8%) | 0.69% -0.122 pp | 0.00% +0.000 pp | USD3.80 -8.2% | 18 qtrs — |
| 27 | CASDIN CAPITAL, LLC | 973.3K +— (+0.0%) | 3.40M +438.0K (+14.8%) | 0.68% -0.086 pp | 0.21% -0.036 pp | USD11.63 -70.0% | 18 qtrs — |
| 28 | BNP PARIBAS ARBITRAGE, SNC | 795.0K +412.4K (+107.8%) | 2.77M +1.6M (+138.5%) | 0.55% +0.253 pp | 0.00% +0.001 pp | USD3.27 +6.7% | 5 qtrs — |
| 29 | ROYCE & ASSOCIATES LP | 735.4K -526.1K (-41.7%) | 2.57M -1.3M (-33.1%) | 0.51% -0.477 pp | 0.03% -0.012 pp | USD2.71 +28.8% | 9 qtrs — |
| 30 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 660.9K +64.3K (+10.8%) | 2.31M +492.9K (+27.2%) | 0.46% -0.008 pp | 0.00% +0.000 pp | USD3.20 +9.1% | 16 qtrs — |
| 31 | DIMENSIONAL FUND ADVISORS LP | 655.9K -66.5K (-9.2%) | 2.29M +93.4K (+4.3%) | 0.46% -0.110 pp | 0.00% +0.000 pp | USD3.23 +8.0% | 13 qtrs — |
| 32 | LAZARD ASSET MANAGEMENT LLC | 555.4K -92.2K (-14.2%) | 1.94M -30.3K (-1.5%) | 0.39% -0.121 pp | 0.00% +0.001 pp | USD2.75 +26.9% | 4 qtrs — |
| 33 | BARCLAYS PLC | 509.0K +377.5K (+287.1%) | 1.78M +1.3M (+253.6%) | 0.35% +0.251 pp | 0.00% +0.000 pp | USD3.47 +0.6% | 9 qtrs — |
| 34 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 470.4K +162.3K (+52.7%) | 1.64M +705.1K (+75.3%) | 0.33% +0.086 pp | 0.11% +0.050 pp | USD3.07 +13.7% | 6 qtrs — |
| 35 | WELLINGTON MANAGEMENT GROUP LLP | 410.1K +32.3K (+8.5%) | 1.43M +282.6K (+24.6%) | 0.29% -0.011 pp | 0.00% +0.000 pp | USD4.01 -13.0% | 8 qtrs — |
| 36 | BANK OF NEW YORK MELLON CORP | 340.6K +8.3K (+2.5%) | 1.19M +178.5K (+17.7%) | 0.24% -0.024 pp | 0.00% +0.000 pp | USD3.36 +3.9% | 18 qtrs — |
| 37 | NUVEEN, LLC | 339.8K -401.7K (-54.2%) | 1.19M -1.1M (-47.4%) | 0.24% -0.345 pp | 0.00% 0.000 pp | USD2.81 +24.2% | 4 qtrs — |
| 38 | TWO SIGMA ADVISERS, LP | 314.3K +276.0K (+720.6%) | 1.10M +980.5K (+842.1%) | 0.22% +0.189 pp | 0.00% +0.002 pp | USD3.42 +2.0% | 8 qtrs — |
| 39 | BANK OF AMERICA CORP /DE/ | 313.8K +38.2K (+13.9%) | 1.10M +257.4K (+30.7%) | 0.22% +0.002 pp | 0.00% +0.000 pp | USD2.69 +29.7% | 18 qtrs — |
| 40 | CENTIVA CAPITAL, LP | 312.7K +312.7K (+100.0%) | 1.09M +1.1M (+100.0%) | 0.22% +0.218 pp | 0.01% +0.009 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 41 | CITADEL ADVISORS LLC | 276.4K +193.5K (+233.4%) | 964.6K +712.6K (+282.8%) | 0.19% +0.127 pp | 0.00% +0.000 pp | USD3.44 +1.5% | 14 qtrs — |
| 42 | PLATINUM INVESTMENT MANAGEMENT LTD | 237.8K +237.8K (+100.0%) | 829.8K +829.8K (+100.0%) | 0.17% +0.165 pp | 0.19% +0.192 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 43 | MILLENNIUM MANAGEMENT LLC | 219.3K -289.6K (-56.9%) | 765.5K -781.6K (-50.5%) | 0.15% -0.246 pp | 0.00% 0.000 pp | USD2.82 +23.8% | 15 qtrs — |
| 44 | PIER 88 INVESTMENT PARTNERS LLC | 205.8K -32.4K (-13.6%) | 718.2K -5.8K (-0.8%) | 0.14% -0.044 pp | 0.16% +0.025 pp | USD3.09 +12.9% | 8 qtrs — |
| 45 | RAFFERTY ASSET MANAGEMENT, LLC | 204.8K +204.8K (+100.0%) | 714.8K +714.8K (+100.0%) | 0.14% +0.143 pp | 0.00% +0.003 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 46 | BRYN MAWR TRUST CO | 189.5K +— (+0.0%) | 661.4K +85.3K (+14.8%) | 0.13% -0.017 pp | 0.02% +0.002 pp | USD3.81 -8.4% | 6 qtrs — |
| 47 | JPMORGAN CHASE & CO | 169.9K -1.6K (-0.9%) | 593.1K +71.7K (+13.8%) | 0.12% -0.016 pp | 0.00% +0.000 pp | USD3.42 +2.0% | 18 qtrs — |
| 48 | RHUMBLINE ADVISERS | 160.7K -10.8K (-6.3%) | 560.9K +39.5K (+7.6%) | 0.11% -0.023 pp | 0.00% +0.000 pp | USD2.96 +17.9% | 16 qtrs — |
| 49 | ALLIANCEBERNSTEIN L.P. | 158.0K +— (+0.0%) | 551.4K +71.1K (+14.8%) | 0.11% -0.014 pp | 0.00% +0.000 pp | USD2.71 +28.8% | 7 qtrs — |
| 50 | WELLS FARGO & COMPANY/MN | 155.6K +65.0K (+71.7%) | 543.2K +267.7K (+97.2%) | 0.11% +0.037 pp | 0.00% +0.000 pp | USD3.12 +11.9% | 18 qtrs — |
| 51 | INDEPENDENT ADVISOR ALLIANCE | 153.9K +— (+0.0%) | 537.0K +69.2K (+14.8%) | 0.11% -0.014 pp | 0.01% +0.001 pp | USD2.67 +30.7% | 4 qtrs — |
| 52 | VICTORY CAPITAL MANAGEMENT INC | 152.3K +602.0 (+0.4%) | 531.5K +70.4K (+15.3%) | 0.11% -0.013 pp | 0.00% +0.000 pp | USD5.40 -35.4% | 8 qtrs — |
| 53 | INSTITUTE FOR WEALTH MANAGEMENT, LLC. | 145.8K +— (+0.0%) | 508.8K +65.6K (+14.8%) | 0.10% -0.013 pp | 0.05% +0.008 pp | USD5.59 -37.6% | 16 qtrs — |
| 54 | AMERICAN CENTURY COMPANIES INC | 143.6K +30.2K (+26.6%) | 501.1K +156.4K (+45.4%) | 0.10% +0.011 pp | 0.00% +0.000 pp | USD3.79 -7.9% | 9 qtrs — |
| 55 | XTX TOPCO LTD | 136.9K +108.4K (+380.9%) | 477.7K +391.2K (+452.1%) | 0.10% +0.073 pp | 0.01% +0.008 pp | USD3.40 +2.6% | 2 qtrs — |
| 56 | RAYMOND JAMES FINANCIAL INC | 135.1K +6.0K (+4.6%) | 471.5K +78.9K (+20.1%) | 0.09% -0.007 pp | 0.00% +0.000 pp | USD2.66 +31.2% | 5 qtrs — |
| 57 | ROYAL BANK OF CANADA | 135.0K +133.6K (+9,694.9%) | 470.0K +466.0K (+11,650.0%) | 0.09% +0.093 pp | 0.00% +0.000 pp | USD3.51 -0.6% | 8 qtrs — |
| 58 | DEUTSCHE BANK AG\ | 92.1K +4.9K (+5.6%) | 321.6K +56.3K (+21.2%) | 0.06% -0.004 pp | 0.00% +0.000 pp | USD2.85 +22.5% | 7 qtrs — |
| 59 | KING LUTHER CAPITAL MANAGEMENT CORP | 77.5K +— (+0.0%) | 270.5K +34.9K (+14.8%) | 0.05% -0.007 pp | 0.00% +0.000 pp | USD3.82 -8.6% | 6 qtrs — |
| 60 | PROFUND ADVISORS LLC | 76.5K +76.5K (+100.0%) | 267.0K +267.0K (+100.0%) | 0.05% +0.053 pp | 0.01% +0.008 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 61 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 75.0K +13.9K (+22.7%) | 261.6K +75.9K (+40.8%) | 0.05% +0.004 pp | 0.00% +0.000 pp | USD3.48 +0.3% | 6 qtrs — |
| 62 | HENGEHOLD CAPITAL MANAGEMENT LLC | 73.7K +— (+0.0%) | 257.3K +33.2K (+14.8%) | 0.05% -0.007 pp | 0.02% +0.003 pp | USD8.43 -58.6% | 16 qtrs — |
| 63 | CREATIVE PLANNING | 73.6K +6.6K (+9.8%) | 256.7K +53.1K (+26.1%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD2.79 +25.1% | 5 qtrs — |
| 64 | HSBC HOLDINGS PLC | 66.2K -2.6K (-3.8%) | 230.2K +25.7K (+12.5%) | 0.05% -0.008 pp | 0.00% +0.000 pp | USD3.10 +12.6% | 13 qtrs — |
| 65 | SBI SECURITIES CO., LTD. | 63.1K +59.3K (+1,569.1%) | 220.3K +208.8K (+1,816.3%) | 0.04% +0.041 pp | 0.01% +0.005 pp | USD3.44 +1.5% | 5 qtrs — |
| 66 | GRIFFIN ASSET MANAGEMENT, INC. | 56.8K +— (+0.0%) | 198.1K +25.5K (+14.8%) | 0.04% -0.005 pp | 0.02% +0.002 pp | USD2.58 +35.3% | 5 qtrs — |
| 67 | ENVESTNET ASSET MANAGEMENT INC | 56.2K +4.0K (+7.7%) | 196.0K +37.5K (+23.6%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD4.91 -28.9% | 10 qtrs — |
| 68 | INVESCO LTD. | 54.6K +6.8K (+14.3%) | 190.4K +45.3K (+31.2%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD3.01 +15.9% | 7 qtrs — |
| 69 | METLIFE INVESTMENT MANAGEMENT, LLC | 52.3K -23.1K (-30.6%) | 182.6K -46.7K (-20.4%) | 0.04% -0.023 pp | 0.00% 0.000 pp | USD3.01 +15.9% | 7 qtrs — |
| 70 | INTECH INVESTMENT MANAGEMENT LLC | 47.2K -6.9K (-12.8%) | 164.6K +142.0 (+0.1%) | 0.03% -0.010 pp | 0.00% +0.000 pp | USD3.02 +15.6% | 6 qtrs — |
| 71 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 41.3K +193.0 (+0.5%) | 144.0K +19.2K (+15.3%) | 0.03% -0.004 pp | 0.00% +0.000 pp | USD2.90 +20.3% | 7 qtrs — |
| 72 | SG AMERICAS SECURITIES, LLC | 40.9K +19.0K (+87.0%) | 143.0K +76.0K (+113.4%) | 0.03% +0.011 pp | 0.00% +0.000 pp | USD3.06 +14.1% | 5 qtrs — |
| 73 | AXQ CAPITAL, LP | 40.1K -16.7K (-29.4%) | 140.0K -32.6K (-18.9%) | 0.03% -0.017 pp | 0.03% -0.035 pp | USD3.04 +14.8% | 2 qtrs — |
| 74 | VISTA CAPITAL PARTNERS, INC. | 39.3K -4.0K (-9.2%) | 137.2K +5.5K (+4.2%) | 0.03% -0.007 pp | 0.01% +0.000 pp | USD3.32 +5.1% | 15 qtrs — |
| 75 | AQR CAPITAL MANAGEMENT LLC | 34.8K -555.0 (-1.6%) | 121.5K +14.0K (+13.0%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD2.83 +23.3% | 6 qtrs — |
| 76 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 34.5K +8.3K (+31.6%) | 120.4K +40.7K (+51.1%) | 0.02% +0.004 pp | 0.01% +0.003 pp | USD2.83 +23.3% | 5 qtrs — |
| 77 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 33.7K +— (+0.0%) | 117.4K +15.1K (+14.8%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD2.70 +29.3% | 5 qtrs — |
| 78 | CITIGROUP INC | 30.8K +9.1K (+42.1%) | 107.4K +41.6K (+63.1%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD3.63 -3.9% | 18 qtrs — |
| 79 | CLARIUS GROUP, LLC | 30.0K +— (+0.0%) | 104.7K +13.5K (+14.8%) | 0.02% -0.003 pp | 0.01% +0.001 pp | USD1.32 +164.4% | 17 qtrs — |
| 80 | ALPHA CUBED INVESTMENTS, LLC | 26.2K +— (+0.0%) | 91.5K +11.8K (+14.8%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD2.68 +30.2% | 5 qtrs — |
| 81 | LPL FINANCIAL LLC | 25.1K +3.6K (+16.7%) | 87.6K +22.2K (+33.9%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD4.71 -25.9% | 8 qtrs — |
| 82 | NEW YORK STATE COMMON RETIREMENT FUND | 24.7K +— (+0.0%) | 86.2K +11.1K (+14.8%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD3.01 +15.9% | 7 qtrs — |
| 83 | VOYA INVESTMENT MANAGEMENT LLC | 23.3K +4.0K (+21.0%) | 81.3K +22.8K (+38.9%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD3.00 +16.3% | 7 qtrs — |
| 84 | SCIENTECH RESEARCH LLC | 21.6K +11.5K (+114.6%) | 75.2K +44.7K (+146.3%) | 0.02% +0.007 pp | 0.05% +0.037 pp | USD3.28 +6.4% | 2 qtrs — |
| 85 | JANE STREET GROUP, LLC | 21.2K -500.0 (-2.3%) | 74.0K +8.0K (+12.2%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD3.04 +14.8% | 2 qtrs — |
| 86 | ADVISOR GROUP HOLDINGS, INC. | 20.3K +9.7K (+90.7%) | 70.9K +40.4K (+132.5%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD3.10 +12.6% | 10 qtrs — |
| 87 | KESTRA PRIVATE WEALTH SERVICES, LLC | 20.3K +— (+0.0%) | 70.8K +9.1K (+14.8%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD2.59 +34.7% | 5 qtrs — |
| 88 | DKM WEALTH MANAGEMENT, INC. | 20.0K +— (+0.0%) | 69.8K +9.0K (+14.8%) | 0.01% -0.002 pp | 0.05% +0.003 pp | USD2.57 +35.8% | 3 qtrs — |
| 89 | DELAP WEALTH ADVISORY, LLC | 19.5K +— (+0.0%) | 68.0K +7.0K (+11.5%) | 0.01% -0.002 pp | 0.02% -0.002 pp | USD2.51 +39.0% | 4 qtrs — |
| 90 | SKOPOS LABS, INC. | 18.9K -2.6K (-12.1%) | 65.1K -185.0 (-0.3%) | 0.01% -0.004 pp | 0.00% -0.004 pp | USD3.04 +14.8% | 3 qtrs — |
| 91 | CHERRY CREEK INVESTMENT ADVISORS, INC. | 18.6K +26.0 (+0.1%) | 65.0K +8.5K (+15.0%) | 0.01% -0.002 pp | 0.03% +0.003 pp | USD3.82 -8.6% | 6 qtrs — |
| 92 | ABEL HALL, LLC | 15.4K +15.4K (+100.0%) | 53.8K +53.8K (+100.0%) | 0.01% +0.011 pp | 0.01% +0.013 pp | USD3.49 +0.0% | 1 qtrs NEW |
| 93 | JONES FINANCIAL COMPANIES LLLP | 15.0K +2.6K (+21.4%) | 52.2K +18.6K (+55.2%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD2.86 +22.0% | 7 qtrs — |
| 94 | CRESSET ASSET MANAGEMENT, LLC | 14.5K +— (+0.0%) | 50.6K +6.5K (+14.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.52 +38.5% | 14 qtrs — |
| 95 | COMMONWEALTH EQUITY SERVICES, LLC | 14.3K +14.3K (+100.0%) | 49.8K +49.8K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD3.49 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.08
Neutral
Ratio by volume
3.00
Bullish
Buys
14
Sells
13
Shares acquired
3.95M
Shares disposed
809.6K
Cash buys
1.00
Cash sales
2.00
Net activity
+3,136,217
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Busch Andreas | Officer | P-Purchase | A | Common Stock | 100,000 | 2.29 | 229.0K | 421,446 | D | ↗ |
| 2026-03-03 | Walker Shelby J. | Officer | F-InKind | D | Common Stock | 9,825 | 2.80 | 27.5K | 139,775 | D | ↗ |
| 2026-03-03 | McClain Sean | Director / Officer | F-InKind | D | Common Stock | 25,316 | 2.80 | 70.9K | 8,715,451 | D | ↗ |
| 2026-03-03 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 10,848 | 2.80 | 30.4K | 499,783 | D | ↗ |
| 2026-03-03 | Busch Andreas | Officer | F-InKind | D | Common Stock | 1,257 | 2.80 | 3.5K | 321,446 | D | ↗ |
| 2026-03-03 | Bedrick Todd | Officer | F-InKind | D | Common Stock | 5,282 | 2.80 | 14.8K | 216,942 | D | ↗ |
| 2026-03-02 | Walker Shelby J. | Officer | A-Award | A | Common Stock | 90,300 | 0.00 | — | 149,600 | D | ↗ |
| 2026-03-02 | Pangalos Menelas N | Director | A-Award | A | Stock Option (right to buy) | 22,800 | 2.80 | 63.8K | 22,800 | D | ↗ |
| 2026-03-02 | McClain Sean | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,603,200 | 2.80 | 4.49M | 1,603,200 | D | ↗ |
| 2026-03-02 | Jonasson Zachariah | Officer | A-Award | A | Common Stock | 135,400 | 0.00 | — | 510,631 | D | ↗ |
| 2026-03-02 | Bedrick Todd | Officer | A-Award | A | Common Stock | 49,600 | 0.00 | — | 222,224 | D | ↗ |
| 2026-02-27 | Pangalos Menelas N | Director | P-Purchase | A | Common Stock | 75,095 | 2.74 | 205.8K | 189,055 | D | ↗ |
| 2026-02-23 | McClain Sean | Director / Officer | M-Exempt | A | Common Stock | 396,399 | 1.21 | 479.6K | 8,730,966 | D | ↗ |
| 2026-02-03 | Busch Andreas | Officer | F-InKind | D | Common Stock | 1,469 | 2.99 | 4.4K | 322,703 | D | ↗ |
| 2026-02-02 | McClain Sean | Director / Officer | S-Sale | D | Common Stock | 26,761 | 2.99 | 80.0K | 8,334,567 | D | ↗ |
| 2026-02-02 | Jonasson Zachariah | Officer | S-Sale | D | Common Stock | 17,496 | 2.99 | 52.3K | 383,538 | D | ↗ |
| 2026-02-02 | Bedrick Todd | Officer | F-InKind | D | Common Stock | 3,659 | 2.99 | 10.9K | 172,624 | D | ↗ |
| 2026-01-28 | Bedrick Todd | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 176,283 | D | ↗ |
| 2025-12-05 | VAN HOUTEN FRANS | Director | P-Purchase | A | Common Stock | 40,000 | 3.72 | 148.8K | 63,320 | D | ↗ |
| 2025-11-30 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 8,320 | 3.17 | 26.4K | 401,034 | D | ↗ |
| 2025-10-14 | McClain Sean | Director / Officer | F-InKind | D | Common Stock | 23,293 | 3.68 | 85.7K | 8,361,328 | D | ↗ |
| 2025-10-14 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 387 | 3.68 | 1.4K | 409,354 | D | ↗ |
| 2025-10-14 | Busch Andreas | Officer | F-InKind | D | Common Stock | 3,092 | 3.68 | 11.4K | 324,172 | D | ↗ |
| 2025-10-14 | Bedrick Todd | Officer | F-InKind | D | Common Stock | 21,950 | 3.68 | 80.8K | 161,283 | D | ↗ |
| 2025-09-22 | Pangalos Menelas N | Director | P-Purchase | A | Common Stock | 95,785 | 2.66 | 254.8K | 113,960 | D | ↗ |
| 2025-09-22 | Bedrick Todd | Officer | P-Purchase | A | Common Stock | 10,000 | 2.70 | 27.0K | 180,428 | D | ↗ |
| 2025-08-31 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 8,319 | 2.39 | 19.9K | 409,741 | D | ↗ |
| 2025-07-28 | Busch Andreas | Officer | P-Purchase | A | Common Stock | 50,000 | 3.04 | 152.0K | 327,264 | D | ↗ |
| 2025-07-07 | Szela Mary T | Director | A-Award | A | Stock Option (right to buy) | 178,400 | 2.58 | 460.3K | 178,400 | D | ↗ |
| 2025-06-11 | VAN HOUTEN FRANS | Director | A-Award | A | Common Stock | 14,500 | 0.00 | — | 23,320 | D | ↗ |
| 2025-06-11 | Sirosh Joseph | Director | A-Award | A | Common Stock | 14,500 | 0.00 | — | 23,320 | D | ↗ |
| 2025-06-11 | Rabinovitsj Daniel A | Director | A-Award | A | Common Stock | 14,500 | 0.00 | — | 23,320 | D | ↗ |
| 2025-06-11 | Pangalos Menelas N | Director | A-Award | A | Common Stock | 14,500 | 0.00 | — | 18,175 | D | ↗ |
| 2025-06-11 | MCGINNIS KAREN K | Director | A-Award | A | Common Stock | 14,500 | 0.00 | — | 38,320 | D | ↗ |
| 2025-05-31 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 5,194 | 2.65 | 13.8K | 418,060 | D | ↗ |
| 2025-03-03 | Walker Shelby J. | Officer | A-Award | A | Common Stock | 59,300 | 0.00 | — | 59,300 | D | ↗ |
| 2025-03-03 | McClain Sean | Director / Officer | A-Award | A | Common Stock | 190,200 | 0.00 | — | 8,384,621 | D | ↗ |
| 2025-03-03 | Jonasson Zachariah | Officer | A-Award | A | Common Stock | 81,500 | 0.00 | — | 423,254 | D | ↗ |
| 2025-03-03 | Busch Andreas | Officer | A-Award | A | Common Stock | 23,700 | 0.00 | — | 277,264 | D | ↗ |
| 2025-03-03 | Bedrick Todd | Officer | A-Award | A | Stock Option (right to buy) | 117,300 | 3.42 | 401.2K | 117,300 | D | ↗ |
| 2025-02-28 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 5,219 | 4.04 | 21.1K | 341,754 | D | ↗ |
| 2025-02-01 | McClain Sean | Director / Officer | F-InKind | D | Common Stock | 16,991 | 3.71 | 63.0K | 8,194,421 | D | ↗ |
| 2025-02-01 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 11,567 | 3.71 | 42.9K | 346,973 | D | ↗ |
| 2025-02-01 | Busch Andreas | Officer | F-InKind | D | Common Stock | 1,469 | 3.71 | 5.4K | 253,564 | D | ↗ |
| 2025-02-01 | Bedrick Todd | Officer | F-InKind | D | Common Stock | 2,630 | 3.71 | 9.8K | 138,127 | D | ↗ |
| 2024-11-30 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 5,194 | 3.05 | 15.8K | 358,540 | D | ↗ |
| 2024-10-12 | McClain Sean | Director / Officer | F-InKind | D | Common Stock | 14,543 | 4.07 | 59.2K | 8,211,412 | D | ↗ |
| 2024-10-12 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 242 | 4.07 | 984.94 | 363,734 | D | ↗ |
| 2024-10-12 | Busch Andreas | Officer | F-InKind | D | Common Stock | 3,092 | 4.07 | 12.6K | 255,033 | D | ↗ |
| 2024-10-12 | Bedrick Todd | Officer | F-InKind | D | Common Stock | 15,606 | 4.07 | 63.5K | 139,064 | D | ↗ |
| 2024-08-31 | Jonasson Zachariah | Officer | F-InKind | D | Common Stock | 20,775 | 4.40 | 91.4K | 363,976 | — | ↗ |
| 2024-07-01 | Walker Shelby J. | Officer | A-Award | A | Stock Option (right to buy) | 613,000 | 3.01 | 1.85M | 613,000 | — | ↗ |
| 2024-06-27 | Walker Shelby J. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-13 | Jonasson Zachariah | Officer | M-Exempt | A | Common Stock | 28,700 | 3.39 | 97.3K | 404,610 | — | ↗ |
| 2024-06-12 | VAN HOUTEN FRANS | Director | A-Award | A | Stock Option (right to buy) | 36,274 | 4.96 | 179.9K | 36,274 | — | ↗ |
| 2024-06-12 | Sirosh Joseph | Director | A-Award | A | Common Stock | 8,820 | 0.00 | — | 8,820 | — | ↗ |
| 2024-06-12 | Redmile Group, LLC | Director | A-Award | A | Stock Option (Right to Buy) | 36,274 | 4.96 | 179.9K | 36,274 | — | ↗ |
| 2024-06-12 | Rabinovitsj Daniel A | Director | A-Award | A | Stock Option (right to buy) | 36,274 | 4.96 | 179.9K | 36,274 | — | ↗ |
| 2024-06-12 | Pangalos Menelas N | Director | A-Award | A | Common Stock | 3,675 | 0.00 | — | 3,675 | — | ↗ |
| 2024-06-12 | Nagpal Amrit | Director | A-Award | A | Common Stock | 8,820 | 0.00 | — | 8,820 | — | ↗ |
| 2024-06-12 | MCGINNIS KAREN K | Director | A-Award | A | Common Stock | 8,820 | 0.00 | — | 23,820 | — | ↗ |
| 2024-05-22 | Phoenix Venture Partners II LP | 10% Owner | S-Sale | D | Common Stock | 3,100,000 | 4.40 | 13.64M | 11,279,522 | — | ↗ |
| 2024-03-19 | McClain Sean | Director / Officer | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 8,225,955 | — | ↗ |
| 2024-03-01 | Redmile Group, LLC | Director | P-Purchase | A | Common Stock | 222,222 | 4.50 | 1,000.0K | 8,253,316 | — | ↗ |
| 2024-02-01 | McClain Sean | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 766,000 | 4.40 | 3.37M | 766,000 | — | ↗ |
| 2024-02-01 | Jonasson Zachariah | Officer | A-Award | A | Common Stock | 114,010 | 0.00 | — | 375,910 | — | ↗ |
| 2024-02-01 | Busch Andreas | Officer | A-Award | A | Common Stock | 83,125 | 0.00 | — | 258,125 | — | ↗ |
| 2024-02-01 | Bedrick Todd | Officer | A-Award | A | Common Stock | 20,570 | 0.00 | — | 154,670 | — | ↗ |
| 2024-01-02 | Pangalos Menelas N | Director | A-Award | A | Stock Option (right to buy) | 106,200 | 3.69 | 391.9K | 106,200 | — | ↗ |
| 2024-01-01 | Pangalos Menelas N | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Phoenix Venture Partners II LP | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-12 | McClain Sean | Director / Officer | A-Award | A | Common Stock | 175,000 | 0.00 | — | 6,543,955 | — | ↗ |
| 2023-10-12 | Jonasson Zachariah | Director / Officer | A-Award | A | Common Stock | 2,900 | 0.00 | — | 261,900 | — | ↗ |
| 2023-10-12 | Busch Andreas | Officer | A-Award | A | Common Stock | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2023-10-12 | Bedrick Todd | Officer | A-Award | A | Common Stock | 131,100 | 0.00 | — | 134,100 | — | ↗ |
| 2023-09-01 | Jonasson Zachariah | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,000,000 | 1.87 | 1.87M | 1,000,000 | — | ↗ |
| 2023-06-14 | Sirosh Joseph | Director | A-Award | A | Stock Option (right to buy) | 53,100 | 1.68 | 89.2K | 53,100 | — | ↗ |
| 2023-06-14 | Redmile Group, LLC | Director | A-Award | A | Stock Option (Right to Buy) | 53,100 | 1.68 | 89.2K | 53,100 | — | ↗ |
| 2023-06-14 | Rabinovitsj Daniel A | Director | A-Award | A | Stock Option (right to buy) | 30,975 | 1.68 | 52.0K | 30,975 | — | ↗ |
| 2023-06-14 | Nagpal Amrit | Director | A-Award | A | Stock Option (Right to Buy) | 53,100 | 1.68 | 89.2K | 53,100 | — | ↗ |
| 2023-06-14 | MCGINNIS KAREN K | Director | A-Award | A | Stock Option (right to buy) | 53,100 | 1.68 | 89.2K | 53,100 | — | ↗ |
| 2023-06-14 | Jonasson Zachariah | Director | A-Award | A | Stock Option (right to buy) | 53,100 | 1.68 | 89.2K | 53,100 | — | ↗ |
| 2023-06-02 | Houten Frans Van | Director | A-Award | A | Stock Option (right to buy) | 106,200 | 1.88 | 199.7K | 106,200 | — | ↗ |
| 2023-03-01 | SCHIFFMAN GREGORY T | Officer | A-Award | A | Stock Option (right to buy) | 425,000 | 2.01 | 854.3K | 425,000 | — | ↗ |
| 2023-03-01 | McClain Sean | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,300,000 | 2.01 | 2.61M | 1,300,000 | — | ↗ |
| 2023-03-01 | Korman Sarah | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 2.01 | 804.0K | 400,000 | — | ↗ |
| 2023-03-01 | Busch Andreas | Officer | A-Award | A | Stock Option (right to buy) | 550,000 | 2.01 | 1.11M | 550,000 | — | ↗ |
| 2023-03-01 | Bedrick Todd | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 2.01 | 201.0K | 100,000 | — | ↗ |
| 2022-11-01 | Rabinovitsj Daniel A | Director | A-Award | A | Stock Option (right to buy) | 57,400 | 0.00 | — | 57,400 | — | ↗ |
| 2022-10-20 | SCHIFFMAN GREGORY T | Officer | M-Exempt | A | Common Stock | 50,000 | 1.10 | 55.0K | 605,165 | — | ↗ |
| 2022-10-03 | Busch Andreas | Officer | A-Award | A | Stock Option (right to buy) | 2,000,009 | 0.00 | — | 2,000,009 | — | ↗ |
| 2022-07-01 | Korman Sarah | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-01 | Bedrick Todd | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-08 | Sirosh Joseph | Director | A-Award | A | Stock Option (right to buy) | 11,958 | 0.00 | — | 11,958 | — | ↗ |
| 2022-06-08 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 28,700 | 3.39 | 97.3K | 28,700 | — | ↗ |
| 2022-06-08 | Nagpal Amrit | Director | A-Award | A | Stock Option (Right to Buy) | 28,700 | 0.00 | — | 28,700 | — | ↗ |
| 2022-06-08 | Magovcevic-Liebisch Ivana | Director | A-Award | A | Stock Option (right to buy) | 28,700 | 3.39 | 97.3K | 28,700 | — | ↗ |
| 2022-06-08 | MCGINNIS KAREN K | Director | A-Award | A | Stock Option (right to buy) | 28,700 | 0.00 | — | 28,700 | — | ↗ |
| 2022-06-08 | Jonasson Zachariah | Director | A-Award | A | Stock Option (right to buy) | 28,700 | 0.00 | — | 28,700 | — | ↗ |
| 2022-06-08 | Green Jeremy | Director | A-Award | A | Stock Option (Right to Buy) | 28,700 | 0.00 | — | 28,700 | — | ↗ |
| 2022-06-08 | Casdin Eli | Director | A-Award | A | Stock Option (right to buy) | 28,700 | 0.00 | — | 28,700 | — | ↗ |
| 2022-06-08 | Busch Andreas | Director | A-Award | A | Stock Option (right to buy) | 4,783 | 3.39 | 16.2K | 4,783 | — | ↗ |
| 2022-03-17 | Busch Andreas | Director | A-Award | A | Stock Option (right to buy) | 45,180 | 8.87 | 400.7K | 45,180 | — | ↗ |
| 2022-02-21 | Weinstock Matthew | Officer | A-Award | A | Stock Option (right to buy) | 215,000 | 8.27 | 1.78M | 215,000 | — | ↗ |
| 2022-02-21 | SCHIFFMAN GREGORY T | Officer | A-Award | A | Stock Option (right to buy) | 190,000 | 8.27 | 1.57M | 190,000 | — | ↗ |
| 2022-02-21 | McClain Sean | Director / Officer | A-Award | A | Stock Option (right to buy) | 635,850 | 8.27 | 5.26M | 635,850 | — | ↗ |
| 2022-02-21 | Korman Sarah | Officer | A-Award | A | Stock Option (right to buy) | 160,000 | 8.27 | 1.32M | 160,000 | — | ↗ |
| 2022-02-21 | Bedrick Todd | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 8.27 | 827.0K | 100,000 | — | ↗ |
| 2022-02-09 | Korman Sarah | Officer | P-Purchase | A | Common Stock | 4,250 | 7.96 | 33.8K | 14,250 | — | ↗ |
| 2022-01-20 | Bedrick Todd | Officer | P-Purchase | A | Common Stock | 2,000 | 7.50 | 15.0K | 3,000 | — | ↗ |
| 2022-01-19 | McClain Sean | Director / Officer | P-Purchase | A | Common Stock | 7,155 | 6.92 | 49.5K | 6,368,955 | — | ↗ |
| 2022-01-07 | Sirosh Joseph | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-07 | Korman Sarah | Officer | A-Award | A | Stock Option (right to buy) | 437,172 | 7.19 | 3.14M | 437,172 | — | ↗ |
| 2021-08-13 | Phoenix Venture Partners II LP | 10% Owner | X-InTheMoney | A | Common Stock | 307,211 | 0.30 | 93.0K | 14,492,813 | — | ↗ |
| 2021-07-26 | Redmile Group, LLC | Director | P-Purchase | A | Common Stock | 1,875,000 | 16.00 | 30.00M | 8,031,094 | — | ↗ |
| 2021-07-26 | Pihl Andreas | Officer | C-Conversion | A | Common Stock | 50,610 | 0.00 | — | 607,937 | — | ↗ |
| 2021-07-26 | Phoenix Venture Partners II LP | 10% Owner | C-Conversion | A | Common Stock | 33,675 | 0.00 | — | 14,185,602 | — | ↗ |
| 2021-07-26 | McClain Sean | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 600 | 16.00 | 9.6K | 6,361,800 | — | ↗ |
| 2021-07-26 | MCGINNIS KAREN K | Director | P-Purchase | A | Common Stock | 15,000 | 16.00 | 240.0K | 15,000 | — | ↗ |
| 2021-07-26 | Korman Sarah | Officer | P-Purchase | A | Common Stock | 10,000 | 16.00 | 160.0K | 10,000 | — | ↗ |
| 2021-07-26 | Jonasson Zachariah | Director | P-Purchase | A | Common Stock | 9,000 | 16.00 | 144.0K | 9,000 | — | ↗ |
| 2021-07-26 | Casdin Partners Master Fund, L.P. | Director | P-Purchase | A | Common Stock | 1,562,500 | 16.00 | 25.00M | 6,745,333 | — | ↗ |
| 2021-07-26 | Casdin Eli | Director | P-Purchase | A | Common Stock | 1,562,500 | 16.00 | 25.00M | 6,745,333 | — | ↗ |
| 2021-07-26 | Bedrick Todd | Officer | P-Purchase | A | Common Stock | 1,000 | 16.00 | 16.0K | 1,000 | — | ↗ |
| 2021-07-21 | Weinstock Matthew | Officer | — | D | Stock Option (right to buy) | 537,982 | 1.10 | 591.8K | 0 | — | ↗ |
| 2021-07-21 | SCHIFFMAN GREGORY T | Officer | — | D | Common Stock | 0 | 0.00 | — | 555,165 | — | ↗ |
| 2021-07-21 | Redmile Group, LLC | Director / 10% Owner | — | I | Series E Convertible Preferred Stock | 4,209,573 | 0.00 | — | 0 | — | ↗ |
| 2021-07-21 | Pihl Andreas | Officer | — | D | Common Stock | 0 | 0.00 | — | 557,327 | — | ↗ |
| 2021-07-21 | Phoenix Venture Partners II LP | 10% Owner | — | D | Series D-1 Preferred Stock | 84,348 | 0.00 | — | 0 | — | ↗ |
| 2021-07-21 | Nagpal Amrit | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-21 | McClain Sean | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 6,361,200 | — | ↗ |
| 2021-07-21 | Magovcevic-Liebisch Ivana | Director | — | D | Common Stock | 0 | 0.00 | — | 179,328 | — | ↗ |
| 2021-07-21 | MCGINNIS KAREN K | Director | — | D | Stock Option (right to buy) | 147,020 | 1.10 | 161.7K | 0 | — | ↗ |
| 2021-07-21 | Korman Sarah | Officer | — | D | Stock Option (right to buy) | 294,982 | 4.40 | 1.30M | 0 | — | ↗ |
| 2021-07-21 | Jonasson Zachariah | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-21 | Goel Nikhil | Officer | — | D | Stock Option (right to buy) | 586,121 | 4.97 | 2.91M | 0 | — | ↗ |
| 2021-07-21 | Casdin Partners Master Fund, L.P. | Director / 10% Owner | — | D | Convertible Note | 973,260 | 13.12 | 12.77M | 0 | — | ↗ |
| 2021-07-21 | Casdin Eli | Director / 10% Owner | — | I | Convertible Note | 973,260 | 13.12 | 12.77M | 0 | — | ↗ |
| 2021-07-21 | Bedrick Todd | Officer | — | D | Stock Option (right to buy) | 49,546 | 1.10 | 54.5K | 0 | — | ↗ |
| 2021-03-17 | Redmile Group, LLC | Director / 10% Owner | — | I | Convertible Promissory Note | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.0K
Shares Outstanding
155.45M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Sean McClain President, Founder and Chief Executive Officer | 689.9K | — | 650.5K | 1.96M | 372.6K | 14.0K | 3.69M | 70.80% | ↗ |
| 2 | 2025 | Zachariah Jonasson, Ph.D. Chief Financial Officer and Chief Business Officer | 553.5K | — | 650.5K | 839.8K | 249.1K | 14.0K | 2.31M | 64.60% | ↗ |
| 3 | 2025 | Andreas Busch, Ph.D. Chief Innovation Officer* | 712.8K | — | 81.1K | 239.4K | 384.9K | 143.0K | 1.56M | 20.53% | ↗ |
| 4 | 2024 | Sean McClain President, Founder and Chief Executive Officer | 660.4K | — | 6.29M | 2.42M | 396.2K | 13.8K | 9.79M | 89.06% | ↗ |
| 5 | 2024 | Zachariah Jonasson, Ph.D. Chief Financial Officer and Chief Business Officer | 533.0K | — | 501.6K | 1.52M | 266.5K | 13.8K | 2.83M | 71.29% | ↗ |
| 6 | 2024 | Andreas Busch, Ph.D. Chief Innovation Officer* | 654.1K | — | 365.8K | 1.11M | 392.5K | 125.5K | 2.64M | 55.68% | ↗ |
| 7 | 2023 | Sean McClain President, Founder and Chief Executive Officer | 620.0K | — | 231.0K | 1.86M | 372.0K | 13.2K | 3.10M | 67.55% | ↗ |
| 8 | 2023 | Zachariah Jonasson, Ph.D. Chief Financial Officer and Chief Business Officer | 175.3K | 25.0K | 471.3K | 1.40M | 87.7K | 43.6K | 2.20M | 84.96% | ↗ |
| 9 | 2023 | Andreas Busch, Ph.D. Chief Innovation Officer* | 630.2K | — | 231.0K | 787.4K | 415.9K | 86.7K | 2.15M | 47.34% | ↗ |
| 10 | 2022 | Andreas Busch Chief Innovation Officer* | 149.6K | 506.6K | — | 3.95M | 80.2K | 45.0K | 4.73M | 83.49% | ↗ |
| 11 | 2022 | Andreas Busch, Ph.D. Chief Innovation Officer* | 149.6K | 506.6K | — | 3.95M | 80.2K | 45.0K | 4.73M | 83.49% | ↗ |
| 12 | 2022 | Sean McClain President, Founder and Chief Executive Officer | 600.0K | — | — | 3.08M | 324.0K | 12.2K | 4.01M | 76.67% | ↗ |
| 13 | 2022 | Sarah Korman Chief Legal Officer | 414.2K | — | — | 2.66M | 149.1K | 12.2K | 3.24M | 82.22% | ↗ |
| 14 | 2021 | Nikhil Goel former Chief Business Officer and current Chief Strategy Officer | 210.4K | — | — | 4.98M | 70.1K | — | 5.26M | 94.67% | ↗ |
| 15 | 2021 | Sean McClain President, Founder and Chief Executive Officer | 505.3K | 500.0K | 1.61M | 1.11M | — | 11.6K | 3.74M | 72.82% | ↗ |
| 16 | 2021 | Sarah Korman General Counsel | 260.0K | 50.0K | — | 2.13M | 143.6K | 7.8K | 2.59M | 82.16% | ↗ |
| 17 | 2021 | Sarah Korman Chief Legal Officer | 260.0K | 50.0K | — | 2.13M | 143.6K | 7.8K | 2.59M | 82.16% | ↗ |
| 18 | 2021 | Matthew Weinstock Chief Technology Officer | 379.9K | — | — | 1.74M | 192.4K | 11.6K | 2.32M | 74.88% | ↗ |
| 19 | 2020 | Sean McClain President, Founder and Chief Executive Officer | 260.0K | — | 743.8K | — | 125.0K | 25.4K | 1.18M | 62.98% | ↗ |
| 20 | 2020 | Matthew Weinstock Chief Technology Officer | 151.6K | — | — | — | 100.0K | 6.4K | 453.5K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andreas Busch | Chief Innovation Officer & Member of Scientific Advisory Board | 1M | — |
| Sean McClain | Founder, Chief Executive Officer, President & Director | 1M | male |
| Zachariah Jonasson | Chief Business Officer & Chief Financial Officer | 816.5K | — |
| Anders Kassow | Head of Intellectual Property | — | — |
| Christine Lemke | Senior Vice President of Portfolio & Growth Strategy | — | — |
| Jeanne Schreuder SPHR | Senior Vice President of People & Experience | — | female |
| Alexander Khan | CVP of Finance & Head of Investor Relations | — | male |
| Melissa Patterson | Chief of Staff | — | — |
| Ransi Somaratne FACC | Chief Medical Officer | — | — |
| Shelby Walker | Chief Legal Officer | — | female |
| Todd Bedrick | Senior Vice President & Chief Accounting Officer | — | male |
| Wen Sha | Chief of Staff | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ABSI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
